185 related articles for article (PubMed ID: 8324301)
1. Paroxetine. A review of its pharmacology, therapeutic use in depression and therapeutic potential in diabetic neuropathy.
Holliday SM; Plosker GL
Drugs Aging; 1993; 3(3):278-99. PubMed ID: 8324301
[TBL] [Abstract][Full Text] [Related]
2. The clinical pharmacology and use of paroxetine, a new selective serotonin reuptake inhibitor.
Nemeroff CB
Pharmacotherapy; 1994; 14(2):127-38. PubMed ID: 8197030
[TBL] [Abstract][Full Text] [Related]
3. Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.
Dechant KL; Clissold SP
Drugs; 1991 Feb; 41(2):225-53. PubMed ID: 1709852
[TBL] [Abstract][Full Text] [Related]
4. Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders.
Haria M; Fitton A; McTavish D
Drugs Aging; 1994 Apr; 4(4):331-55. PubMed ID: 8019056
[TBL] [Abstract][Full Text] [Related]
5. Paroxetine: an update of its use in psychiatric disorders in adults.
Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL
Drugs; 2002; 62(4):655-703. PubMed ID: 11893234
[TBL] [Abstract][Full Text] [Related]
6. Paroxetine. A pharmacoeconomic evaluation of its use in depression.
Wilde MI; Whittington R
Pharmacoeconomics; 1995 Jul; 8(1):62-81. PubMed ID: 10155603
[TBL] [Abstract][Full Text] [Related]
7. Mirtazapine: a review of its use in major depression.
Holm KJ; Markham A
Drugs; 1999 Apr; 57(4):607-31. PubMed ID: 10235695
[TBL] [Abstract][Full Text] [Related]
8. Mirtazapine : A Review of its Pharmacology and Therapeutic Potential in the Management of Major Depression.
Davis R; Wilde MI
CNS Drugs; 1996 May; 5(5):389-402. PubMed ID: 26071050
[TBL] [Abstract][Full Text] [Related]
9. [Clinical effects of serotonin reuptake inhibitors--a review].
Feighner JP
Fortschr Neurol Psychiatr; 1994 Sep; 62 Suppl 1():9-15. PubMed ID: 7959528
[TBL] [Abstract][Full Text] [Related]
10. Tianeptine: a review of its use in depressive disorders.
Wagstaff AJ; Ormrod D; Spencer CM
CNS Drugs; 2001; 15(3):231-59. PubMed ID: 11463130
[TBL] [Abstract][Full Text] [Related]
11. Paroxetine: an overview of dosage, tolerability, and safety.
Jenner PN
Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 4():69-80. PubMed ID: 1431015
[TBL] [Abstract][Full Text] [Related]
12. Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression.
Davis R; Whittington R; Bryson HM
Drugs; 1997 Apr; 53(4):608-36. PubMed ID: 9098663
[TBL] [Abstract][Full Text] [Related]
13. Paroxetine: an overview of the efficacy and safety of a new selective serotonin reuptake inhibitor in the treatment of depression.
Nemeroff CB
J Clin Psychopharmacol; 1993 Dec; 13(6 Suppl 2):10S-17S. PubMed ID: 8106649
[TBL] [Abstract][Full Text] [Related]
14. A risk-benefit assessment of mirtazapine in the treatment of depression.
Kasper S; Praschak-Rieder N; Tauscher J; Wolf R
Drug Saf; 1997 Oct; 17(4):251-64. PubMed ID: 9352961
[TBL] [Abstract][Full Text] [Related]
15. Fluvoxamine. An updated review of its pharmacology, and therapeutic use in depressive illness.
Wilde MI; Plosker GL; Benfield P
Drugs; 1993 Nov; 46(5):895-924. PubMed ID: 7507038
[TBL] [Abstract][Full Text] [Related]
16. Paroxetine versus amitriptyline for treatment of depression associated with rheumatoid arthritis: a randomized, double blind, parallel group study.
Bird H; Broggini M
J Rheumatol; 2000 Dec; 27(12):2791-7. PubMed ID: 11128665
[TBL] [Abstract][Full Text] [Related]
17. Citalopram. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.
Milne RJ; Goa KL
Drugs; 1991 Mar; 41(3):450-77. PubMed ID: 1711447
[TBL] [Abstract][Full Text] [Related]
18. Venlafaxine. A review of its pharmacology and therapeutic potential in depression.
Holliday SM; Benfield P
Drugs; 1995 Feb; 49(2):280-94. PubMed ID: 7729333
[TBL] [Abstract][Full Text] [Related]
19. Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in older patients with depressive illness.
Harris MG; Benfield P
Drugs Aging; 1995 Jan; 6(1):64-84. PubMed ID: 7696780
[TBL] [Abstract][Full Text] [Related]
20. Multicenter double blind study of paroxetine and amitriptyline in elderly depressed inpatients.
Geretsegger C; Stuppaeck CH; Mair M; Platz T; Fartacek R; Heim M
Psychopharmacology (Berl); 1995 Jun; 119(3):277-81. PubMed ID: 7675961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
